Eisai
Initiates
Sports
Eisai Initiates Rolling Biologics License Application to US FDA for...
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of...